Diverse competitor B cell responses to a germline-targeting priming immunogen in human Ig loci transgenic mice

Torben Schiffner,Anne Palser,Joseph G. Jardine,Alessia Liguori,Sergey Menis,Sebastian Raemisch,Xiaozhen Hu,Daniel W. Kulp,Xiaoning Wang,Jolene K. Diedrich,Bettina Groschel,Oleksandr Kalyuzhniy,Ryan Tingle,Khoa Le,Erik Georgeson,Yumiko Adachi,Michael Kubitz,Elise Landais,John R. Yates III,James C. Paulson,Devin Sok,Paul Kellam,William R. Schief
DOI: https://doi.org/10.1101/2024.01.22.575410
2024-01-23
Abstract:Broadly neutralizing antibodies (bnAbs) have promise to protect against HIV infection, but induction of bnAbs by immunization is an unsolved vaccine design challenge. Germline-targeting priming immunogens aim to initiate the induction of bnAbs by specifically activating rare bnAb-precursor B cells that can subsequently be matured using suitable heterologous boosting and shepherding immunogens. Several pre-clinical studies, and the IAVI G001 human clinical trial, have demonstrated the ability of a germline-targeting priming immunogen, eOD-GT8 60mer, to induce precursors of the VRC01 class of bnAbs. However, much less is known about B cells induced against other epitopes of the immunogen. Here, we performed unbiased analysis of B cells induced by eOD-GT8 60mers in Intelliselect Transgenic mice (Kymice) that are transgenic for the human Ig loci and produce human-like BCRs. B cells isolated with intact eOD-GT8 60mer nanoparticles showed a large diversity of non-VRC01-class B cells, with 38% unique clonotypes and only 5% of BCRs belonging to public lineages shared among all animals. We found that many competitors recognize epitopes in close proximity to or overlapping with the VRC01 epitope. These results indicate that optimal boosting of VRC01-class bnAb-precursor B cells primed by eOD-GT8 60mer might require a first-boost immunogen that minimizes recognition of competitor B cells, and such competitors isolated from Kymice could serve as valuable reagents for boost development.
Immunology
What problem does this paper attempt to address?
This paper primarily discusses the diversity of B-cell responses targeting germline-targeting immunogen eOD-GT8 60mer in human Ig locus transgenic mice (Kymice). eOD-GT8 60mer is a vaccine strategy aimed at activating a wide range of broadly neutralizing antibody (bnAb) precursor B cells, which can then mature through heterologous boosting and antigen-guided selection to fight against HIV infection. The study found that in addition to VRC01-class bnAb precursors, eOD-GT8 60mer could also induce a large number of non-VRC01-class B cells that recognize antigenic epitopes similar to or overlapping with the VRC01 epitope. This suggests that optimizing the enhancement of VRC01-class bnAb precursors may require reducing activation of competitive B cells, and these competitive B cells isolated from Kymice can be valuable reagents for developing enhanced immunogens. The research findings highlight the importance of understanding and reducing "off-target" B-cell responses to optimize germline-targeting vaccine design.